Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: inhalation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
9 July 2012 - 21 September 2012
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Study conducted to GLP in compliance with agreed protocols, with no or minor deviations from standard test guidelines and/or minor methodological deficiencies, which do not affect the quality of the relevant results.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2012
Report date:
2012

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 436 (Acute Inhalation Toxicity: Acute Toxic Class Method)
Deviations:
yes
Remarks:
see below
Principles of method if other than guideline:
The mean mass median aerodynamic diameter (MMAD), which was 4.90, is outside the range given in test guidelines (1-4 µm). This deviation is considered to be due to the physical characteristics of the test material and is not considered to have affected the validity of the study.
GLP compliance:
yes (incl. QA statement)
Test type:
acute toxic class method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
Praseodymium(III,IV) oxide
EC Number:
234-857-9
EC Name:
Praseodymium(III,IV) oxide
Cas Number:
12037-29-5
Molecular formula:
O11Pr6
IUPAC Name:
tetrakis(λ⁴-praseodymium(4+)) dipraseodymium(3+) undecaoxidandiide
Test material form:
solid: particulate/powder
Details on test material:
Appearance: Brown powder
Storage conditions: Room temperature, in the dark

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Strain: RccHan:WIST
- Age at study initiation: approximately 8 - 12 weeks
- Weight at study initiation: 200 - 350 g
- Fasting period before study: no
- Housing: The animals were housed in groups of up to three by sex in solid-floor polypropylene cages with stainless steel lids, furnished with softwood flakes and provided with environmental enrichment items: wooden chew blocks and cardboard “fun tunnels”.
- Diet (e.g. ad libitum): With the exception of the exposure period, free access to food was allowed; Harlan 2014C Rodent Diet, Harlan Laboratories UK Ltd., Oxon, UK.
- Water (e.g. ad libitum): ad libitum with the exception of the exposure period.
- Acclimation period: at least 5 days
- Source: Harlan Laboratories UK Ltd., Oxon, UK. 


ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 - 25 °C
- Humidity (%): 30 - 70 %
- Air changes (per hr): at least 15 per hour
- Photoperiod (hrs dark / hrs light): the lighting was controlled to give twelve hours continuous light and twelve hours darkness.

Administration / exposure

Route of administration:
inhalation: dust
Type of inhalation exposure:
nose only
Vehicle:
clean air
Details on inhalation exposure:
ATMOSPHERE GENERATION
A dust atmosphere was produced from the test material using an SAG 410 Solid Aerosol Generator located adjacent to the exposure chamber. The SAG 410 was connected to a metered compressed air supply.
A particle separator was introduced before the aerosol entered the exposure chamber during the sighting study in order to remove large particles and thereby increase the inhalable portion of the generated aerosol. This could not be utilised during the main study exposure as the target concentration could not be achieved with the particle separator attached to the generation equipment. The test material was ground in a Llytron mini grinder prior to use in the main study.
Compressed air was supplied by means of an oil free compressor and passed through a water trap and respiratory quality filters before it was introduced to the SAG 410.
The cylindrical exposure chamber had a volume of approximately 30 litres (dimensions: 28 cm diameter x 50 cm high). The concentration within the chamber was controlled by adjusting the test material feed rate from the SAG 410. The extract from the exposure chamber passed through a ‘scrubber’ trap and was connected with a high efficiency filter to a metered exhaust system. The chamber was maintained under negative pressure.

Prior to the start of the study, test material atmospheres were generated within the exposure chamber. During this characterisation period test material input rates and the generation system were varied in order to achieve the required atmospheric conditions.


EXPOSURE PROCEDURE
Prior to the day of exposure each rat was acclimatised (for approximately 2 hours) to a tapered polycarbonate restraining tube. During the day of exposure, each rat was individually held in a tapered, polycarbonate restraining tube fitted onto a single tier of the exposure chamber and sealed by means of a rubber ‘O’ ring.
A target concentration of 5.0 mg/L was used for the exposure. The mean achieved concentration was 104 % of target.


EXPOSURE CHAMBER TEMPERATURE AND RELATIVE HUMIDITY
The temperature and relative humidity inside the exposure chamber were measured by an electronic thermometer/humidity meter located in a vacant port in the animals’ breathing zone of the chamber and recorded every thirty minutes.


EXPOSURE CHAMBER OXYGEN CONCENTRATION
Oxygen levels within the exposure chamber were measured by an electronic oxygen analyser located in a port in the animals' breathing zone. The test atmosphere was generated to contain at least 19 % oxygen.
The MMAD was 4.90 µm, resulting in an inhalable fraction (% <4 µm) of 41.1. The geometric standard deviation was 2.50.


EXPOSURE CHAMBER ATMOSPHERE CONCENTRATION
The actual chamber concentration was measured at regular intervals during the exposure period. The gravimetric method used glass fibre filters placed in a filter holder. The holder was temporarily sealed in a vacant port in the exposure chamber in the animals’ breathing zone and a suitable, known volume of exposure chamber air was drawn through the filter using a vacuum pump.
Each filter was weighed before and after sampling in order to calculate the weight of collected test material. The difference in the two weights, divided by the volume of atmosphere sampled, gave the actual chamber concentration.
The nominal chamber concentration was calculated by dividing the mass of test material used by the total volume of air passed through the chamber.
The nominal concentration is 889 % of the actual mean achieved atmosphere concentration and shows that keeping the aerosol airborne was difficult.


PARTICLE SIZE DISTRIBUTION
The particle size of the generated atmosphere inside the exposure chamber was determined three times during the exposure period using a Marple Personal Cascade Impactor. This device consisted of six impactor stages (9.8, 6.0, 3.5, 1.6, 0.93 and 0.52 µm cut points) with stainless steel collection substrates and a back up glass fibre filter, housed in an aluminium sampler. The sampler was temporarily sealed in a sampling port in the animals’ breathing zone and a suitable, known volume of exposure chamber air was drawn through it using a vacuum pump.
The collection substrates and backup filter were weighed before and after sampling and the weight of the test material, collected at each stage, calculated by the difference.
The mean amount for each stage was used to determine the cumulative amount below each cut-off point size. In this way, the proportion (%) of aerosol less than 9.8, 6.0, 3.5, 1.6, 0.93 and 0.52 µm was calculated.
The resulting values were converted to probits and plotted against Log10 cut-point size. From this plot, the Mass Median Aerodynamic Diameter (MMAD) was determined (as the 50 % point) and the geometric standard deviation was calculated. In addition the proportion (%) of aerosol less than 4 µm (considered to be the inhalable fraction) was determined.
Analytical verification of test atmosphere concentrations:
yes
Remarks:
The test atmosphere was sampled seventeen times during the exposure period and the actual concentration of the test material calculated.
Duration of exposure:
4 h
Concentrations:
5.21 mg/L
No. of animals per sex per dose:
3 animals per sex per dose
Control animals:
no
Details on study design:
- Duration of observation period following administration: all animals were observed for clinical signs at hourly intervals during exposure, immediately on removal from the restraining tubes at the end of exposure, one hour after termination of exposure and subsequently once daily for up to 14 days. Any evidence of overt toxicity was recorded at each observation.
- Frequency of weighing: Individual bodyweights were recorded on arrival, prior to treatment on the day of exposure and on Days 1, 3, 7 and 14.
- Necropsy of survivors performed: yes. At the end of the 14 day observation period the animals were killed by intravenous overdose of sodium pentobarbitone. All animals were subjected to a full external and internal examination, and any macroscopic abnormalities were recorded. The respiratory tract was subjected to a detailed macroscopic examination for signs of irritancy or local toxicity.

Results and discussion

Preliminary study:
SIGHTING EXPOSURE
During characterisation, a group of two rats (one male, one female) were exposed to an atmosphere of the test material at a mean achieved atmosphere concentration of 2.26 mg/L for approximately four hours. Increased respiratory rate was the only significant observation noted in both animals during exposure, on removal from the chamber and one hour post-exposure, red/brown staining around the snout was also noted in both animals on removal. One day post-exposure, both animals exhibited increased respiratory rate and hunched posture only. Both animals recovered quickly to appear normal on Day 3 or Day 4 post-exposure.
Effect levels
Sex:
male/female
Dose descriptor:
LC50
Effect level:
> 5.21 mg/L air (analytical)
Based on:
test mat.
Exp. duration:
4 h
Mortality:
There was no mortality during the study.
Clinical signs:
other: In addition to the observations considered to be due to the restraint procedure (such as hunched posture, pilo-erection, wet fur and fur staining due to the test material), increased respiratory rate was noted in all animals during exposure, on removal fr
Body weight:
All animals exhibited bodyweight losses or showed no bodyweight gain on the first day post-exposure. All animals exhibited bodyweight gains during the remainder of the observation period, with the exception of one female animal which showed no bodyweight gain from Days 1 to 3 post-exposure.
Gross pathology:
Four animals (all males and one female) exhibited dark patches on the lungs at necropsy.

Any other information on results incl. tables

Table 1: Exposure Chamber Atmosphere Concentrations

Duration of Exposure (minutes)

Net Weight of Sample (mg)

Volume of Air Sampled (L)

Chamber Flow Rate (L/min)

Atmosphere Concentration (mg/L)

5

9.81

2

60

4.91

15

10.56

2

60

5.28

29

10.72

2

60

5.36

45

10.17

2

60

5.09

60

10.05

2

60

5.03

75

10.74

2

60

5.37

90

10.31

2

60

5.16

105

11.94

2

60

5.97

120

10.18

2

60

5.09

135

10.46

2

60

5.23

150

10.32

2

60

5.16

165

10.76

2

60

5.38

181

9.80

2

60

4.90

195

10.09

2

60

5.05

210

10.66

2

60

5.33

225

10.67

2

60

5.34

235

9.84

2

60

4.92

Mean achieved atmosphere concentration: 5.21 mg/L (standard deviation 0.26)

 

Nominal Concentration

-Test material used: 714 g

-Air flow: 60 L/min

-Total generation time: 257 minutes*

-Nominal concentration: 46.3 mg/L

 

*Test atmospheres were generated for a total of 17 minutes prior to animal insertion to ensure that the test material concentration was being achieved.

 

Table 2: Particle Size Distribution - Cascade Impactor Data

Impactor Stage Number

Cut Point (µm)

Amount Collected (mg) Per Sample Number

Mean Amount Collected (mg)

1

2

3

3

9.8

0.69

0.82

0.54

0.68

4

6.0

0.67

0.84

0.55

0.69

5

3.5

0.76

0.93

0.54

0.74

6

1.6

0.53

0.67

0.57

0.59

7

0.93

0.34

0.43

0.29

0.35

8

0.52

0.02

0.09

0.12

0.08

Back-up filter

<0.52

0.00

0.05

0.02

0.02

Total mean amount of test material collected: 3.15 mg

 

Table 3: Particle Size Distribution - Calculation

Cut Point (µm)

Log10 Cut Point

Mean Cumulative Amount Less Than Cut Point

(mg)

(%)

Probit

9.8

0.991

2.47

78.4

5.79

6.0

0.778

1.78

56.5

5.16

3.5

0.544

1.04

33.0

4.56

1.6

0.204

0.45

14.3

3.93

0.93

-0.032

0.10

3.18

3.14

0.52

-0.284

0.02

0.635

2.51

MMAD: 4.90 µm

Geometric standard deviation: 2.50

Predicted amount <4 µm: 41.1 %

Table 4: Individual Bodyweights

Animal Number and Sex

Bodyweight (g) on Day:

Increment (g) During Days:

-9

0

1

3

7

14

-9 to 0

0 to 1

1 to 3

3 to 7

7 to 14

1 Male

241

288

280

297

312

319

47

-8

17

15

7

2 Male

229

263

254

264

270

290

34

-9

10

6

20

3 Male

236

271

266

271

283

294

35

-5

5

12

11

4 Female

191

226

219

229

236

245

35

-7

10

7

9

5 Female

199

228

228

234

238

250

29

0

6

4

12

6 Female

187

218

216

216

221

224

31

-2

0

5

3

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
The 4 hour LC50 was determined to be > 5.21 mg/L, therefore the test material requires no classification under the conditions of this study in accordance with EU criteria.
Executive summary:

An acute inhalation study was conducted to assess the toxicity potential of the test material in accordance with the standardised guideline OECD 436.

Male and female RccHan:WIST strain rats (3 per sex) were exposed (nose only) for 4 hours to a dust atmosphere containing the test material at a mean concentration of 5.21 mg/L, with a MMAD of 4.90 µm.

Following exposure, the animals were observed for 14 days for signs of mortality and toxicity. At the end of the observation period, all animals were subjected to necropsy.

No deaths occurred throughout the study and the 4 hour LC50 was therefore determined to be > 5.21 mg/L. The test material requires no classification under the conditions of this study in accordance with EU criteria.